Prime Highlights-
- French officials visited Lunit in Seoul to explore healthcare AI collaboration in Europe.
- Talks focused on expanding AI use in Europe’s public healthcare under France’s France 2030 program.
Key Facts-
- SGPI leads France 2030, a €54 billion investment plan supporting innovation in Europe.
- Lunit already works in France through UniHA and Vidi Group partnerships in medical AI.
Background-
The General Secretariat for Investment sent a delegation of French officials to Lunit’s headquarters in Seoul, where conversations centred on healthcare AI cooperation and the shape of possible investment in Europe.
The visit centered on how AI tools could be put to work within France’s public healthcare system, framed within the country’s France 2030 strategy, a sweeping national program channeling resources into health, energy, technology and other priority sectors.
The delegation was led by Secretary General Bruno Bonnell and operates out of the French Prime Minister’s Office, which oversees France 2030, a national investment program worth 54 billion euros.
Medical AI uptake in public healthcare across France and Europe took center stage, with both delegations working through investment trends and scoping out where collaboration could move forward.
The visit also came at a diplomatically significant moment, coinciding with a summit between the leaders of South Korea and France that placed technology collaboration high on the agenda.
Lunit used the occasion to walk the delegation through its medical AI portfolio, its plans for European expansion and its current business activities on the continent.
The company already supplies a breast cancer diagnostic AI solution to UniHA, France’s largest public healthcare purchasing group, and has established a partnership with Vidi Group, a French diagnostic imaging network. Both tie-ups have helped Lunit build a credible foothold in the European healthcare market and sharpen its standing in medical imaging AI.
Officials on both sides described the discussions as a reflection of the growing closeness between South Korea and France on advanced healthcare technology. The two countries are looking to take that relationship further, with medical AI and public healthcare innovation expected to sit at the heart of future collaboration.
